<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220726055557N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-08-07</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Investigating the effect of vision exercises and balance exercises</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Vision and balance training ON vision perception, motor function and quality of life in diabetic patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-08-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>85</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64956</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research, Randomization description: Patients will be randomly assigned to four groups vision exercises, balance exercises, combined exercises, and control groups with a 1:1 allocation ratio. Block randomization method will be used for random allocation of patients. The randomized patient allocation sequence will be created by the random allocation software, the name of the software is Random Allocation Software, we put the data in the software, and then the software itself does it, Blinding description: After allocation, it was not possible to keep the trainer blind to each participant's allocated intervention.  But the evaluator remained blind.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Type 2 diabetes.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group: the group of balance exercises, which includes three sessions per week and one hour each session for balance exercises, which includes functional strength and resistance exercises and some yoga movements. (subject to the principle of overload). Intervention 2: Intervention group: eye exercises that are held on the 8th of every week for three sessions and each session is one hour. The exercises include eye saccade exercises and tracking exercises of the week. (subject to the principle of overload). Intervention 3: Intervention group:The third intervention group, where balance and eye combined exercises will be held in eight weeks, three sessions per week, and each session will be held for one hour.  Half of the class will be on balance exercises, which are the exercises of the first intervention group, and half of the class will be on eye exercises, which are in the second intervention class.  (subject to the principle of overload). Intervention 4: Control group: In this group, only people will be helped for the pre-test and post-test, the pre-tests will be taken from the control group in the first session, just like the three intervention groups, and after eight weeks, the post-test will be taken from the group, just like the three intervention groups.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The provided files are in the form of a complete Excel file, in which the history of the patients, fasting blood sugar and hemoglobin A1C levels, underlying diseases and surgery, and the extent of the disease are described.
  The site consent form will be designed and provided to each participant
  After completing the intervention steps, a full report of the clinical interventions will be prepared and will be accessible in the file as a document

When:
The Excel file of the participants' profile can be accessed after it is completed and before the start of the intervention
 An informed consent form will be available at the first session after the start of the intervention when all participants have signed it
 The file of clinical interventions will be available in the last session of the intervention and after the results and approval of the relevant judges and professors and after printing.

To whom:
People related to this research will have access permission, such as supervisors, advisors, and referees.
 Apart from the details of the participants, other researchers working in academic and scientific institutions will have the necessary access

Conditions:
Access to all parts of this study will be granted solely for treatment and to supplement and improve research

Where to obtain:
To access this information, they can go to the email address:
 khazaelihanieh200@gmail.com
 And
 rokhsareh.badami@gmail.com
 Visit

How to obtain:
Applicants can access the information after one working week after entering the email address

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hanieh Khazaeli</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.26, Rostam Niya Ave, North Montazeri Blvd, Najaf Abad Town</address>
        <city>Najaf Abad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8514913551</zip>
        <telephone>+98 31 4251 5080</telephone>
        <email>khazaelihanieh200@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Rokhsare Badami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University Blvd, Arghavanieh Ave, Eastern Jey St, Esfahan Town</address>
        <city>Esfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8155139998</zip>
        <telephone>0098 31 35354001-9</telephone>
        <email>rokhsareh.badami@khuisf.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Gender and age of (women with type 2 dibetes 50 to 65 years)
The only medicine that can be taken is metformin tablets
Voluntary participation and informed consent
Absence of kidney, cardiovascular, orthopedic and neurological diseases
Not using walkers, canes and other aids
Balance disorder
Literate to read and write to answer the questionnaire and written consent
Good visual acuity
Having type 2 diabetes that has been diagnosed for more than 12 months
Not having regular sports activities other than practical exercises by the researcher during the course</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>65 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Drug use other than metformin tablets
Simultaneous participation in orthopedic treatment programs (physiotherapy, neuropathy or surgery) and exercise in line with studying during the course.
Age less than 50 years and more than 65 years
Patients less than one year old who have been diagnosed with type 2 diabetes</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E11</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>دیابت نوع 2 و چشم پزشکی</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group: the group of balance exercises, which includes three sessions per week and one hour each session for balance exercises, which includes functional strength and resistance exercises and some yoga movements. (subject to the principle of overload)</i_keyword>
      <i_keyword>Intervention group: eye exercises that are held on the 8th of every week for three sessions and each session is one hour. The exercises include eye saccade exercises and tracking exercises of the week. (subject to the principle of overload)</i_keyword>
      <i_keyword>Intervention group:The third intervention group, where balance and eye combined exercises will be held in eight weeks, three sessions per week, and each session will be held for one hour.  Half of the class will be on balance exercises, which are the exercises of the first intervention group, and half of the class will be on eye exercises, which are in the second intervention class.  (subject to the principle of overload)</i_keyword>
      <i_keyword>Control group: In this group, only people will be helped for the pre-test and post-test, the pre-tests will be taken from the control group in the first session, just like the three intervention groups, and after eight weeks, the post-test will be taken from the group, just like the three intervention groups.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Balance level of people with type 2 diabetes. Timepoint: The first session will be taken at the beginning of the pre-test intervention and the post-test will be taken after eight weeks of intervention. Method of measurement: To measure balance from the Berg Balance Scale and Tinetti Balance Test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The level of visual perception of people with type 2 diabetes. Timepoint: The first session will be taken at the beginning of the pre-test intervention and the post-test will be taken after eight weeks of intervention. Method of measurement: Using the National Eye Institute Visual Functioning Questionnaire 25.</sec_outcome>
      <sec_outcome>Motor Function of people with type 2 diabetes. Timepoint: The first session will be taken at the beginning of the pre-test intervention and the post-test will be taken after eight weeks of intervention. Method of measurement: Using the 6-minute walk test 6Movement Walk Test.</sec_outcome>
      <sec_outcome>Quality of life of people with type 2 diabetes. Timepoint: The first session will be taken at the beginning of the pre-test intervention and the post-test will be taken after eight weeks of intervention. Method of measurement: Using the Quality of Life 36 Question test and the Hospital Anxiety and Depressin Scale questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Hanieh Khazaeli</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-07-03</approval_date>
        <contact_name>Ethics Committee of Azad University of Khorasgan branch</contact_name>
        <contact_address>University Blvd, Arghavanieh Ave, Eastern Jey Str, Esfahan Town Esfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
